Study of Cetuximab in Squamous Cell Carcinoma of the Skin Expressing EGFR
Status:
Completed
Trial end date:
2009-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether cetuximab is effective in the treatment of
locally advanced or metastatic squamous cell carcinoma of the skin expressing EGFR.